Skip to content
Boost Up Blog – Lifestyle
Author:
Cognition Therapeutics, Inc.
Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
May 21, 2026
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
May 7, 2026
←
Previous Page
1
2